Other competencies
- 2019 – Head of Work Package 2 “Drug-induced liver injury” (DILI) and academic coordinator of the IMI TransBioLine Consortium (Translational Safety Biomarker Pipeline) of the European Union
- 2018 – Pro-Euro DILI Network (Prof. Gerd A Kullak Ublick. | PRO-EURO DILI NETWORK)
- 2008 – 2011: Member of the Federal Drug Commission, Federal Ministry of Health, Bern / Switzerland
- 2013 – Member of the jury for the annual Paul Martini Prize (Paul Martini Foundation)
Career
| since 2006 | Professor, Director of the Department of Clinical Pharmacology and Toxicology, University Hospital Zurich |
|---|---|
| 2001 – 2006 | SNSF Professorship, Department of Clinical Pharmacology and Toxicology and Department of Gastroenterology and Hepatology, University Hospital Zurich |
| 1999 – 2001 | Attending Physician Hepatology, Department of Clinical Pharmacology and Toxicology and Department of Gastroenterology and Hepatology, University Hospital Zurich |
| 1998 – 2005 | Specialist certification in internal medicine with a focus on gastroenterology, as well as clinical pharmacology and toxicology |
| 1992 – 1994 | Postdoctoral fellow in the Department of Clinical Pharmacology and Toxicology, University Hospital Zurich in collaboration with the Liver Center, Albert Einstein College of Medicine, Bronx/New York |
| 1991 – 1999 | Resident at the Medical Clinic II, Grosshadern Hospital, University of Munich/Germany |
| 1991 | Dissertation on “Mechanisms of action of plant sterols on the inhibition of cholesterol absorption: comparison of sitosterol and sitostanol” at the Department of Clinical Pharmacology at the University of Bonn/Germany |
| 1990 | State Examination in Human Medicine, University of Munich / Germany |
| 1984 – 1990 | Medical studies, Universities of Bonn, Munich, London (UK) and Stanford (USA) |
| 1983 | General Certificate of Education (GCE), Oxford and Cambridge Examinations Board, St. Paul’s School, London/England |
Most important memberships
- Co-Chair of the Dissertation Committee, Faculty of Medicine, University of Zurich
- Member of the University Competence Center “Biomedical Ethics and Law” (MER)
- Member of the PhD program “Drug Discovery” (UZH – Drug Discovery Network Zurich)
- Member of the PhD program “BioMed” (UZH – PhD Program Biomedicine)
- Swiss Society for Clinical Pharmacology and Toxicology (SSCPT)
- Swiss Society of General Internal Medicine (SGAIM – SSMIG – SSGIM)
- Investigator of the Swiss Society for the Study of the Liver
- NCCR Kidney (National Competence Center for Research)
- Zurich Center for Integrative Human Physiology
- Member of the Scientific Committee of the Swiss IBD Cohort Study
Membership of international professional organizations
- American Association for the Study of Liver Diseases
- Pro-Euro DILI Registry (PRO-EURO DILI NETWORK | Prospective European Drug-Induced Liver Injury Network)
- International Serious Adverse Event Consortium (International Serious Adverse Event Consortium (iSAEC) | Columbia University Department of Systems Biology) in the context of the IDILIC study (International Drug-Induced Liver Injury Consortium) at Newcastle University, UK
- IQ DILI Consortium